^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Anti-SLAMF7 CAR T cells
i
Other names: Anti-SLAMF7 CAR T cells, Anti-SLAMF7 CAR
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
National Cancer Center, University of Wuerzburg
Drug class:
CS-1-targeted CAR-T immunotherapy
Related drugs:
